Basics Nautilus Biotechnology, Inc. IPO Date: August 7, 2020 Sector: Healthcare Industry: Biotech Market Cap: $179.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 3.29% Avg Daily Range (30 D): $0.05 | 5.05% Avg Daily Range (90 D): $0.03 | 3.85% Institutional Daily Volume Avg Daily Volume: .18M Avg Daily Volume (30 D): .39M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 133 Avg Trade Size (Sh.) (30 D): 292 Avg Trade Size (Sh.) (90 D): 273 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $2.57M Avg Inst. Trade (90 D): $2.57M Avg Inst. Trade Volume: .44M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.99M Avg Closing Trade (30 D): $2.57M Avg Closing Trade (90 D): $2.57M Avg Closing Volume: 654.98K     News May 3, 2024 @ 4:00 PM Nautilus Biotechnology (NAUT) Upgraded to Buy: Her... Source: Zacks Equity Research Apr 30, 2024 @ 12:00 PM Nautilus Biotechnology Reports First Quarter 2024 ... Source: Nautilus Biotechnology Inc. Feb 22, 2024 @ 1:00 PM Nautilus Biotechnology to Participate in the TD Co... Source: Nautilus Biotechnology Inc. Nov 1, 2023 @ 12:05 PM Nautilus Biotechnology Appoints Martin Huber, Ph.D... Source: Nautilus Biotechnology Inc. Oct 31, 2023 @ 12:05 PM Nautilus Biotechnology Reports Third Quarter 2023 ... Source: Nautilus Biotechnology Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.12 $-.13 Diluted EPS $-.12 $-.13 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ $ -15.03M $ -16.61M Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ $ 1.22M $ 5.59M PE Ratio